Back to top

AbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study

Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) is running a new observational study called “A Concordance Study ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AbbVie Inc. (ABBV)